Femasys announces financial results for quarter ended june 30, 2024 and provides corporate update

Company gained ce mark approval for four of its women's health products and completed buildout of commercial team for its infertility portfolio company gained ce mark approval for four of its women's health products and completed buildout of commercial team for its infertility portfolio
FEMY Ratings Summary
FEMY Quant Ranking